SCS Capital Management LLC Sells 9,562 Shares of SPDR S&P Biotech ETF $XBI

SCS Capital Management LLC lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 44.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,070 shares of the exchange traded fund’s stock after selling 9,562 shares during the quarter. SCS Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,472,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of XBI. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after acquiring an additional 2,900,633 shares during the period. Assetmark Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares in the last quarter. Greenwoods Asset Management Hong Kong Ltd. acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $55,613,000. Ameriprise Financial Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares in the last quarter. Finally, Main Street Research LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $43,959,000.

SPDR S&P Biotech ETF Trading Down 2.2%

Shares of XBI opened at $133.62 on Tuesday. The stock has a 50 day simple moving average of $131.22 and a 200-day simple moving average of $126.19. SPDR S&P Biotech ETF has a 1 year low of $79.49 and a 1 year high of $139.19. The stock has a market cap of $8.52 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.